Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Positive New for Sun Pharma- Promising Phase 2 study results of inhibitor ILUMYA reported

      Positive New for Sun Pharma- Promising Phase 2 study results of inhibitor ILUMYA reported

      Farhat Nasim15 Jun 2019 5:00 PM IST
      Mumbai: After facing a series of setbacks on the stock market front Dilip Shanghvi led Sun Pharmaceuticals Limited (Sun Pharma) recently saw some...
      Zydus gets USFDA nod for Omega-3-Acid Ethyl Esters capsules

      Zydus gets USFDA nod for Omega-3-Acid Ethyl Esters capsules

      Farhat Nasim15 Jun 2019 2:46 PM IST
      Omega-3-acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of certain blood fat...
      Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx

      Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx

      Farhat Nasim15 Jun 2019 10:00 AM IST
      Dr Reddy's (Dr Reddys) Labs said Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete...
      Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

      Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

      Farhat Nasim13 Jun 2019 3:23 PM IST
      New Delhi: Breaking the alleged cartel of public sector general insurance companies when it comes to mediclaim treatment, the Delhi High court has...
      Alembic Pharma to raise up to Rs 300 crore via issuance of NDCs

      Alembic Pharma to raise up to Rs 300 crore via issuance of NDCs

      Farhat Nasim13 Jun 2019 10:00 AM IST
      Alembic Pharma has approved the issue of unsecured listed rated redeemable non-convertible debentures (NCDs) of up to Rs 300 crore on a private...
      End of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGS

      End of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGS

      Farhat Nasim12 Jun 2019 11:30 AM IST
      Indian drug regulator, the Central Drugs Standard Control Organisation (CDSCO), under the health ministry has proposed that manufacture, sale and...
      Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore

      Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore

      Farhat Nasim12 Jun 2019 11:29 AM IST
      New Delhi: Yes Bank has reduced its stake in Fortis healthcare (FHL) by around 2 per cent by selling over 1.51 crore shares of the company in various...
      CDSCO apex committee streamlines drug approval process post clinical trial

      CDSCO apex committee streamlines drug approval process post clinical trial

      Farhat Nasim11 Jun 2019 5:08 PM IST
      New Delhi: In a move to oversee clinical trials on new chemical entities, the Central Drug Standard Control Organisation’s (CDSCO) apex committee has...
      Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

      Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

      Farhat Nasim11 Jun 2019 3:31 PM IST
      New Delhi: Bringing in a third party, the Delhi High Court has directed Radha Soami Satsang Beas (RSSB) chief Gurinder Singh Dhillon and his family...
      Abbott expands cardiac arrhythmias portfolio in India with launch of advanced mapping catheter

      Abbott expands cardiac arrhythmias portfolio in India with launch of advanced mapping catheter

      Farhat Nasim11 Jun 2019 12:28 PM IST
      Mumbai: Abbott today announced the launch of its HD grid mapping catheter, which is sensor enabled in India. This product received the USFDA clearance...
      Relief for JnJ: Central Drugs Laboratory reaffirms safety of JnJ baby shampoo

      Relief for JnJ: Central Drugs Laboratory reaffirms safety of JnJ baby shampoo

      Farhat Nasim10 Jun 2019 3:51 PM IST
      The Central Drugs Laboratory in Kolkata conducted tests on two different lots of the JnJ baby shampoo after the company contested a finding of the...
      Dr Reddys yields positive results from phase 2b study of new psoriasis drug

      Dr Reddys yields positive results from phase 2b study of new psoriasis drug

      Farhat Nasim10 Jun 2019 2:02 PM IST
      The detailed safety and efficacy data from the study would be presented in future dermatology conferences, reads Dr Reddy's (Dr Reddys) recent...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok